To give an update in the field of haemostasis scientists and
clinicians fromoverseas and European countries met to dis-
cuss the new trends in pathophysiology and clinical impli-
cations. This book is devoted to the interactions of endo-
thelial functions, tissue factors, coagulation inhibitors
and haemostasis as well as detection and prophylaxis of
thromboembolism. Data are presented of significant new re-
search work on molecular and clinical approaches to diseases
in haemostasis.
Inhaltsverzeichnis
Endothelial Functions and Haemostasis. - Structure, Shape and Function of Glycosaminoglycans. - Structure and Metabolism of Glycosaminoglycans. - Fibrin Polymerization and Its Role in Regulating Haemostasis. - Function of von Willebrand Factor in Plasma. - Biosynthesis and Assembly of the Factor VIII von Willebrand Factor Complex. - Modulation of Endothelial Cell Function by Hypoxia: Perturbation of Barrier and Anticoagulant Function and Induction of a Novel Procoagulant Activity. - Tissue Factors and Endothelium. - Platelet Adhesion; A Concerted Action of Hemodynamic and Biochemical Processes. - Modulation of Endothelial Functions by Advanced Glycosylation End Products. - Procogulant Activities of Leukocytes. - Cytokine Induced Stimulation of Endothelial Cells in Vitro. - Anti-Platelet Treatment of Metastasis. - The Molecular Anatomy of Vitronectin as Extracellular Regulator Protein: Multifunctional Properties of the Heparin-Binding Domain. - Mode of Action of Annexin V (Vascular Anticoagulant Alpha), A Protein Synthesized by the Vessel Wall. - Coagulation Inhibitors and Haemostasis. - Clinical Pharmacologal Profile of Low Molecular Weight Heparins. - Anticoagulant Actions of Sulphated Polysaccharides. - Development of Synthetic Proteinase Inhibitors as Anticoagulant Agents. - Antithrombin and Its Deficiency States. - New Coagulation Inhibitors. - Biological Function of Vitamin K Antagonists. - Plasminogen Activator Inhibitors: Biological Effects. - Fibrin-Specific Clot Lysis with Single Chain Urokinase-Type Plasminogen Activator (scu-PA). - Antibody Mediated Thrombolysis: Promise and Problems. - Thromboembolism: Detection and Prophylaxis. - Causation and Prevention of Coronary Thrombosis: Present Situation. - Non-Invasiva Diagnostic Techniques in Deep Vein Thrombosis. - Evaluationof the Bleeding Effects of Antithrombotic Drugs. - List of Participants. - List of Sponsors.